This video is brought to you by Sekur: https://ept.ms/3yW0Wul At the Conservative Political Action Conference last week, we spoke with Dr. Peter McCullough and John Leake, co-authors of the best-selling book “The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex.” The two describe how Dr. McCullough and his colleagues went from saving…
[Premiering at 1PM ET] Dr. McCullough: Smear Campaign to Censor Early COVID Treatment Led by Bio-Pharmaceutical Complex
[Premiering Now] Dr. McCullough: Smear Campaign to Censor Early COVID Treatment Led by Bio-Pharmaceutical Complex
This video is brought to you by Sekur: https://ept.ms/3yW0Wul At the Conservative Political Action Conference last week, we spoke with Dr. Peter McCullough and John Leake, co-authors of the best-selling book “The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex.” The two describe how Dr. McCullough and his colleagues went from saving…
Dr. McCullough: Smear Campaign to Censor Early COVID Treatment Led by Bio-Pharmaceutical Complex
This video is brought to you by Sekur: https://ept.ms/3yW0Wul At the Conservative Political Action Conference last week, we spoke with Dr. Peter McCullough and John Leake, co-authors of the best-selling book “The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex.” The two describe how Dr. McCullough and his colleagues went from saving…
‘We Have a Corrupt Medical System in This Country’: Sen. Ron Johnson
From the early days of the pandemic, Sen. Ron Johnson (R-Wis.) has been trying to hold U.S. public health agencies accountable on many issues, including why the agencies censored early treatment options for COVID-19, pushed vaccine mandates, and demonstrated a lack of integrity and transparency involving the vaccine data and reporting. After conducting two years…
The Paradox That Haunts New Antibiotics
Forget COVID-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics. There’s no Operation Warp Speed charging to rescue us from the germs that cause these infections,…
Advertising Business Linked to Deaths and Greenwashing
Investment in these companies has skyrocketed in recent years, but many aren’t what they claim to be. Take this firm for example, despite their virtual signaling – look at what they actually own. I urge you: Do not be fooled by these hucksters. STORY AT-A-GLANCE Advertising agencies wield great power over public opinion, and prosecutors…
How Pfizer Profited From the Pandemic
Internal research shows Pfizer’s executives have been announcing the next stage in the fight against the pandemic before government officials can even study the issue, annoying experts and scientists, and leaving the public questioning whom they can trust. Who’s really in charge? STORY AT-A-GLANCE The COVID-19 pandemic has been a real boon to Pfizer. Not…
US Gives Pfizer $3.2 Billion for Ineffective COVID Vax
The US government has agreed to purchase another 105 million doses of Pfizer’s COVID-19 shots for $3.2 billion. They’re intended for a fall vaccination campaign, even though millions of COVID-19 doses have already been wasted, as demand plummets amidst news of their ineffectiveness. STORY AT-A-GLANCE The U.S. Department of Health and Human Services announced that…
Big Pharma Paid $24 Million to 1% of US Oncologists, Many in High-Profile Positions: Study
One percent of U.S. cancer doctors, many with leadership roles in hospitals, academia, national health institutes, and guideline-making, received over $24 million in payments from cancer pharmaceutical companies in 2018, according to a new study by Queen’s University in Canada. The study found that 139 oncologists—representing 1 percent of all American cancer doctors—were given over $100,000…
Big Pharma Paid $24 Million to 1 Percent of US Oncologists, Many in High-Profile Positions: Study
One percent of U.S. cancer doctors, many with leadership roles in hospitals, academia, national health institutes, and guideline-making, received over $24 million in payments from cancer pharmaceutical companies in 2018, according to a new study by Queen’s University in Canada. The study found that 139 oncologists—representing 1 percent of all American cancer doctors—were given over $100,000…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta